After two years of cancelled and entirely virtual conferences, ISPOR was finally able to return to an in-person format in Washington D.C. this May. The conference adopted a hybrid approach, with a full programme of live in-person sessions, many of which were also available to view online, as well as a number of online only sessions. Costello Medical launched back into ISPOR by sending a team of eight to attend the conference in person, with four team members from our US office in Boston joined by four colleagues from the UK.
The conference was well attended, with a full exhibition hall of booths and poster presentations to accompany the extensive programme of educational content. We were delighted to have two Costello Medical research posters at the conference exploring technical methods for cost-effectiveness analysis:
Notably, the topics driving the agenda seemed to have undergone a step-change at this year’s conference. For a number of years it has felt (to me at least!) as though “pricing and reimbursement challenges for novel therapies” and “capturing additional elements of value” have been the dominant presence amongst the conference programme. Whilst still present this year – reflecting that these challenges have by no means been resolved – these topics did feel less of a focus. The tagline for the conference was “The Future of HEOR in Patient-Driven Digital Healthcare Systems” and the conference programme approached this topic from three key angles across the plenaries and a number of supporting Issue Panels, Workshops and Spotlight sessions:
Our eight conference attendees have prepared commentaries on these topics and a number of others that featured throughout the conference. We hope you enjoy reading them!
